Journal
EXPERIMENTAL CELL RESEARCH
Volume 316, Issue 8, Pages 1415-1421Publisher
ELSEVIER INC
DOI: 10.1016/j.yexcr.2010.03.012
Keywords
Cell cycle; Stem cells; CNS development; CDK inhibitors; Cell death
Categories
Funding
- Swedish Childhood Cancer Foundation (BCF)
- Swedish Foundation for Strategic Research (SSF)
- K&A Wallenberg Foundation
- Karolinska Institutet Foundations (KI Cancer)
- Swedish Research Council
- Swedish Cancer Society (CF)
Ask authors/readers for more resources
The proper development of the brain and other organs depends on multiple parameters, including strictly controlled expansion of specific progenitor pools. The regulation of such expansion events includes enzymatic activities that govern the correct number of specific cells to be generated via an orchestrated control of cell proliferation, cell cycle exit, differentiation, cell death etc. Certain proteins in turn exert direct control of these enzymatic activities and thus progenitor pool expansion and organ size. The members of the Cip/Kip family (p21Cip1/p27Kipl/p57Kip2) are well-known regulators of cell cycle exit that interact with and inhibit the activity of cyclin-CDK complexes, whereas members of the p53/p63/p73 family are traditionally associated with regulation of cell death. It has however become clear that the roles for these proteins are not as clear-cut as initially thought. In this review, we discuss the roles for proteins of the Cip/Kip and p53/p63/p73 families in the regulation of cell cycle control, differentiation, and death of neural stem cells. We suggest that these proteins act as molecular interfaces, or pilots, to assure the correct assembly of protein complexes with enzymatic activities at the right place at the right time, thereby regulating essential decisions in multiple cellular events. (C) 2010 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available